Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis
about
A novel surface protein of Trichomonas vaginalis is regulated independently by low iron and contact with vaginal epithelial cells.The route less taken: pulmonary models of enteric Gram-negative infectionUnc119 protects from Shigella infection by inhibiting the Abl family kinasesA synthetic ligand for IgA affinity purification.Covalent homodimers of murine secretory component induced by epitope substitution unravel the capacity of the polymeric Ig receptor to dimerize noncovalently in the absence of IgA ligand.A novel plasmid-encoded serotype conversion mechanism through addition of phosphoethanolamine to the O-antigen of Shigella flexneri.Toward a better understanding of the basis of the molecular mimicry of polysaccharide antigens by peptides: the example of Shigella flexneri 5a.Serotype 1a O-antigen modification: molecular characterization of the genes involved and their novel organization in the Shigella flexneri chromosome.Homeostasis of the gut barrier and potential biomarkers.Identification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD)Interactions of the invasive pathogens Salmonella typhimurium, Listeria monocytogenes, and Shigella flexneri with M cells and murine Peyer's patches.Secretory immunoglobulin A: from mucosal protection to vaccine development.The pathogenesis of Shigella flexneri infection: lessons from in vitro and in vivo studies.Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes.Parameters underlying successful protection with live attenuated mutants in experimental shigellosisPredominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of endemicity.Oral microbial ecology and the role of salivary immunoglobulin ARole of toll-like receptor 4 in the proinflammatory response to Vibrio cholerae O1 El tor strains deficient in production of cholera toxin and accessory toxins.Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans.The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity.Antigen-specific CD8(+) T cells fail to respond to Shigella flexneri.Analysis of virulence and inflammatory potential of Shigella flexneri purine biosynthesis mutantsRecognition of gram-positive intestinal bacteria by hybridoma- and colostrum-derived secretory immunoglobulin A is mediated by carbohydrates.Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cellsTransient suppression of Shigella flexneri type 3 secretion by a protective O-antigen-specific monoclonal IgAPer-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in miceAntibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle.Induction of a local anti-IpaC antibody response in mice by use of a Shigella flexneri 2a vaccine candidate: implications for use of IpaC as a protein carrier.Infection of rabbit Peyer's patches by Shigella flexneri: effect of adhesive or invasive bacterial phenotypes on follicle-associated epitheliumShigella flexneri infection: pathogenesis and vaccine development.Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.Trafficking of Shigella lipopolysaccharide in polarized intestinal epithelial cellsThe contribution of accessory toxins of Vibrio cholerae O1 El Tor to the proinflammatory response in a murine pulmonary cholera model.Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic miceMolecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.Glycan:glycan interactions: High affinity biomolecular interactions that can mediate binding of pathogenic bacteria to host cellsShigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?Correlation of proinflammatory and anti-inflammatory cytokine levels with histopathological changes in an adult mouse lung model of Campylobacter jejuni infection.Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults.Secretory IgA: arresting microbial pathogens at epithelial borders.
P2860
Q25257734-21883B31-71CF-4702-B225-017EB958C80CQ27691303-36DC0161-68A6-4544-AC2E-50211B31BA4BQ28475302-00C1F0B1-D6CA-48C9-9D86-0E3D5E4779ABQ30654760-788850E1-CF00-4D7B-99BD-4A4E057AE52AQ30798700-90A7DE55-09E1-4CDA-A48C-D3C73B6F8FBCQ31103972-FCD2D526-910B-423D-895B-C482AEC816D5Q33226009-60F69B7E-79EB-41AA-BBAC-6C182DDDCD9DQ33635703-29B7B963-7238-4083-9E81-A8508A2080E3Q33715804-5CF8CCCD-07AD-45BA-8CD4-B61FE84EEAF4Q33753646-63A207A7-D989-414C-B220-1B4335A757D0Q33757886-AD05FA5C-8DAA-40C1-8DAA-F9CBDB37A7DFQ33805948-B874BA41-A983-4E2B-9312-B3A87DB1E075Q33955468-833C4D90-650C-4C02-9E25-80B1CD25DDC1Q34001444-6EE5D70A-51B0-44B3-9502-5D6B675F323AQ34006071-5D3339BA-C67E-4E94-BD3A-F8F837B4A03CQ34008763-9F6AC991-2D99-4774-A816-9AE89FE054C6Q34009973-1EC21CA1-E69F-401E-9412-B53B79354A38Q34034170-1FD56FD6-5C7E-49FE-A156-74D5F51DBB68Q34068059-FA922108-7B51-44E4-874D-9B1D9BE76443Q34218284-0C7E3E4E-63B0-4303-B059-A703B6A80E1DQ34931500-D358F691-4301-4BA3-90D6-BA90733366BAQ34941041-453D81AB-5B53-42A7-B9AD-8FCE1C9D94DCQ34948157-86785DA9-4B46-45F6-97C7-997F53E23DACQ34998132-7084C06B-7C84-4E7B-ADBC-7182E792B518Q35006275-302E2FBD-A512-47A2-BA63-AF20A9111CB4Q35117688-85A13BE3-C9A6-41AF-B16A-8EEC13051957Q35182322-8642B311-1B62-4988-8CFF-05C8B058F55CQ35480510-A9A89557-F8B0-4BF6-807C-35774C7AE6E9Q35506252-5A5B9CFA-7374-424D-8354-1B2C398552A9Q35671854-5FB9D13D-785E-45CF-8149-A3BBBC16F4AAQ35688976-B0AE6BF5-9A84-4AA1-86B1-3136F95AE236Q36256650-6EC4E5B0-9A0A-4893-8854-467157588571Q36369684-3EDB75B3-0650-41E7-B44A-A4CF07A475D1Q36404662-0038B41B-2295-4DB5-92DE-8BBC1BDCCB23Q36422508-A43138CF-46AF-40C2-8202-A4E2619D2D4AQ36435129-70163A78-8DFD-43C5-BD1A-CA0B667A8588Q36703588-58B6974D-2CD4-4F6B-9457-BC3CE51EAB37Q36994238-2B6E6786-7A19-40E3-9667-6D34A6BEEB38Q37067290-989D678B-7815-4814-AE1F-D21793FEF600Q37175693-ED37D37B-157C-4418-945E-9D11CED8615B
P2860
Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Monoclonal immunoglobulin A an ...... urine experimental shigellosis
@ast
Monoclonal immunoglobulin A an ...... urine experimental shigellosis
@en
type
label
Monoclonal immunoglobulin A an ...... urine experimental shigellosis
@ast
Monoclonal immunoglobulin A an ...... urine experimental shigellosis
@en
prefLabel
Monoclonal immunoglobulin A an ...... urine experimental shigellosis
@ast
Monoclonal immunoglobulin A an ...... urine experimental shigellosis
@en
P2093
P2860
P921
P356
P1476
Monoclonal immunoglobulin A an ...... urine experimental shigellosis
@en
P2093
Cavaillon JM
Kaufmann M
Kraehenbuhl JP
Michetti P
Phalipon A
Sansonetti P
P2860
P304
P356
10.1084/JEM.182.3.769
P407
P577
1995-09-01T00:00:00Z